U-Chart Analysis:TOWA PHARMACEUTICAL CO.,LTD.:4553

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index TOWA PHARMACEUTICAL CO.,LTD. Go to web site 4553 Medicals 東証プライム March 1, 2000 1994.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet 2024年3月期 TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期 TOWA PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents 29,650 24,257 32,830 22,915 18,713
Other Current AssetsHelp 188,068 158,733 134,034 114,375 102,812
Tangible Fixed AssetsHelp 153,642 127,004 99,873 85,898 81,629
Intangible Fixed AssetHelp 18,018 18,332 18,999 7,913 7,912
Investments and OthersHelp 8,707 8,408 7,297 -20,046 -20,114
Total AssetsHelp 430,653 371,347 332,097 245,668 230,016
Total Current LiabilitiesHelp 85,636 84,139 120,734 54,971 73,687
Total Long-term LiabilitiesHelp 189,124 150,314 79,194 74,098 51,664
Shareholder's EquityHelp 155,893 136,894 132,169 116,599 104,665
Total LiabilitiesHelp 430,653 371,347 332,097 245,668 230,016

TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2024年3月期 TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期 TOWA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales 227,934 208,859 165,615 154,900 110,384
Total Sales 227,934 208,859 165,615 154,900 110,384
Cost of SalesHelp 146,551 136,145 95,429 89,448 59,738
Other Costs and RevenueHelp 65,210 70,513 54,271 51,494 36,143
Total CostsHelp 211,761 206,658 149,700 140,942 95,881
Net RevenueHelp 81,383 72,714 70,186 65,452 50,646
Earnings Before TaxHelp 24,459 4,605 22,246 18,728 20,709
Net IncomeHelp 16,173 2,201 15,915 13,958 14,503
Net Income 16,173 2,201 15,915 13,958 14,503

TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2024年3月期 TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期 TOWA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help 8,213 2,545 22,129 12,354 19,166
Investing Cash Flow(ICF)Help -40,394 -30,284 -59,729 -9,100 -39,541
Financing Cash FlowHelp 35,407 17,481 46,540 184 11,748
Exchange Difference of Cash and Cash EquivalentsHelp 2,167 1,685 975 761 689
Net Increase and Decrease in Cash and Cash Equivalentsn 5,393 -8,573 9,915 4,199 -7,938

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

TOWA PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

DENKA SEIKEN Co.,Ltd.
Carna Biosciences,Inc.
Immuno-Biological Laboratories Co., Ltd.
TSUMURA & CO.
WAKAMOTO PHARMACEUTICAL CO.,LTD.
TAIKO PHARMACEUTICAL CO.,LTD.
CellSource Co., Ltd.
CHUGAI PHARMACEUTICAL CO., LTD.
Daito Pharmaceutical Co.,Ltd.
Mochida Pharmaceutical Co.,Ltd.